Heart Failure Society of America’s Post

Referral patterns and co-management strategies of retinal disease are changing the way patients are being treated. When you factor in systemic conditions, like cardiac, cerebral, and renal diseases that may be detected in OCT scans, the playing field broadens. Are you offering your target audience the resources they need to leverage your solutions for patient care? Make a difference: https://lnkd.in/gW6-Mjmp

🌟 Personalized Care for Every Sickle Cell Warrior 🌟 At the Foundation for Sickle Cell Disease Research, we understand that each journey with sickle cell disease is unique. That's why our dedicated doctors and hematologists specialize in personalized treatment plans, tailored to fit the individual needs of each patient. From finding the perfect combination of medications to relieve pain and reduce inflammation, to conducting thorough tests and regular exams, we're committed to adjusting and optimizing your treatment every step of the way. Our mission? To ensure you can embrace life to the fullest, with the highest quality of life possible. Because you deserve care that's as unique as you are. Let's work together towards a brighter, healthier future. #SickleCellCare #PersonalizedMedicine #FightSickleCell #HighQualityLife #SickleCellAwareness #FSCDR #HealthcareHeroes #SickleCellWarriors #PatientCenteredCare #InnovativeTreatment #HealthWellness #SickleCellSupport #LivingWithSCD

Eosinophilia😱 Slight eosinophilia is not uncommen, but have you had a patient with HES. They can present in many ways so remember to check leukocytes and diff in patients with skin, lung, gastrointestinal, cardiac and other diseases. Maybe there is a common factor💫 To learn more, follow the posts next week💫

Don’t miss Dr. Andrade’s talk the “Impact of Ablation on AF Progression” on Friday, February 2nd at AF Symposium during the 7:30AM ET session. The PROGRESSIVE-AF trial clearly demonstrates that early treatment with the Medtronic Cryoballoon is disease modifying through a 75% reduction in the rate of progression from paroxysmal to persistent AF compared to AADs over long term follow-up. #EPEEPS Risks may include: Stroke, unintended tissue damage, creation of other heart arrhythmias, and death. Link: https://bit.ly/42nZyAu See risk/benefit info: https://bit.ly/42juRMT

Time to diagnosis is the first major hurdle for those with pulmonary fibrosis. Many go un- or misdiagnosed for YEARS. Even as long as 5 or 10 years, or more. Yet "time" is critical for those living with PF. "Time" can: -- Be the difference between having a chance at extending life expectancy with one of the two approved antifibrotics or not having antifibrotic treatment available -- Allow for finding the cause of PF (if not IPF - idiopathic PF: PF with no known cause) and treating that cause in an attempt to slow progression of PF -- Allow for educating patients and their loved ones about better self care and minimizing or removing those things in their lifestyle or environment that might further progression of their PF -- Give patients and their loved ones more time to prepare for what's coming; emotionally, financially, personally (allowing for filling those "bucket list" items) Time to diagnosis can be everything to someone living with PF. Help reduce time to diagnosis by sharing this great infographic provided by Chest and Three Lakes Foundation and also find the very best in pulmonary fibrosis education and support through the Breathe Support Network at www.BreatheSupport.org. https://lnkd.in/g7sQk2Qb #LIVEwithPF #timetoPFdiagnosis #pulmonaryfibrosis #BreatheSupport

The #HeartFlow Analysis has helped physicians at more than 800 hospitals and clinics worldwide to improve care for more than 250,000 patients with coronary artery disease. Learn why partnering with HeartFlow has helped these organizations succeed in our case studies: https://bit.ly/3ni4bt7. #FFRCT #CCTA #AI #heartcare #yesCCT

Coronary Artery Disease (CAD) is the most common type of #heartdisease, affecting nearly half the adult population. The #HeartFlowAnalysis could help people who are exhibiting symptoms of #coronaryarterydisease and are referred by a physician. Learn the four most common symptoms of CAD: https://bit.ly/3TxmyKN.

Coronary Artery Disease (CAD) is the most common type of #heartdisease, affecting nearly half the adult population. The #HeartFlowAnalysis could help people who are exhibiting symptoms of #coronaryarterydisease and are referred by a physician. Learn the four most common symptoms of CAD: https://bit.ly/3TxmyKN.

Today is World Encephalitis Day 🧠 1 person every minute is diagnosed with encephalitis, a condition that may lead to death or life-changing complications. Saving time in the diagnosis of encephalitis can help improve patient outcomes. ⏱️ #WorldEncephalitisDay  👉 Discover bioMérieux's solutions for rapid results: https://lnkd.in/e27DEQhx

The 2021 ACC/AHA Guidelines highlighted the use of Coronary CTA + FFRCT as a front-line pathway. This growing support is reflected in the 250,000 patients HeartFlow has served but is only a fraction of the 18+ million people living with coronary artery disease in the US. Learn more about our novel technology and how it compares to other non-invasive CAD tests: https://bit.ly/45Rdwex.